Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Fortress Biotech Inc (FBIO)

Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 43,347
  • Shares Outstanding, K 22,814
  • Annual Sales, $ 84,510 K
  • Annual Income, $ -60,640 K
  • EBIT $ -101 M
  • EBITDA $ -90 M
  • 60-Month Beta 1.75
  • Price/Sales 0.51
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 315.08% ( +100.64%)
  • Historical Volatility 55.43%
  • IV Percentile 97%
  • IV Rank 64.10%
  • IV High 475.55% on 02/21/24
  • IV Low 28.61% on 07/17/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 747
  • Volume Avg (30-Day) 154
  • Put/Call OI Ratio 0.12
  • Today's Open Interest 4,809
  • Open Int (30-Day) 4,159

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.27
  • Number of Estimates 1
  • High Estimate -0.27
  • Low Estimate -0.27
  • Prior Year -0.94
  • Growth Rate Est. (year over year) +71.28%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.4000 +35.71%
on 10/02/24
2.1000 -9.52%
on 10/29/24
+0.4700 (+32.87%)
since 10/01/24
3-Month
1.3550 +40.22%
on 09/24/24
2.1599 -12.03%
on 08/27/24
-0.1900 (-9.09%)
since 08/01/24
52-Week
1.2400 +53.23%
on 11/10/23
4.4300 -57.11%
on 12/28/23
+0.2200 (+13.10%)
since 11/01/23

Most Recent Stories

More News
Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference

FBIO : 1.9000 (unch)
DERM : 6.17 (+7.30%)
Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit

FBIO : 1.9000 (unch)
ATXI : 2.24 (-6.67%)
Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

FBIO : 1.9000 (unch)
DERM : 6.17 (+7.30%)
Fortress Biotech: Q2 Earnings Snapshot

Fortress Biotech: Q2 Earnings Snapshot

FBIO : 1.9000 (unch)
Fortress Biotech: Q1 Earnings Snapshot

Fortress Biotech: Q1 Earnings Snapshot

FBIO : 1.9000 (unch)
Fortress Biotech: Q3 Earnings Snapshot

Fortress Biotech: Q3 Earnings Snapshot

FBIO : 1.9000 (unch)
Fortress Biotech: Q2 Earnings Snapshot

Fortress Biotech: Q2 Earnings Snapshot

FBIO : 1.9000 (unch)
Fortress Biotech: Q1 Earnings Snapshot

Fortress Biotech: Q1 Earnings Snapshot

FBIO : 1.9000 (unch)
Fortress Biotech: Q3 Earnings Snapshot

Fortress Biotech: Q3 Earnings Snapshot

FBIO : 1.9000 (unch)
Fortress Biotech Subsidiary Helocyte Announces Grant that Could Provide Over $20 Million from National Institute of Allergy and Infectious Diseases for Phase 2 Study of Triplex for Control of Cytomegalovirus in Patients Undergoing Liver Transplantation

MIAMI, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on...

FBIO : 1.9000 (unch)

Business Summary

Fortress Biotech, Inc. is a biopharmaceutical company. The company is engaged in acquiring, developing and commercializing novel pharmaceutical and biotechnology products. Fortress Biotech, Inc., formerly known as Coronado Biosciences, Inc., is based in NEW YORK, United States.

See More

Key Turning Points

3rd Resistance Point 2.0450
2nd Resistance Point 2.0000
1st Resistance Point 1.9500
Last Price 1.9000
1st Support Level 1.8550
2nd Support Level 1.8100
3rd Support Level 1.7600

See More

52-Week High 4.4300
Fibonacci 61.8% 3.2114
Fibonacci 50% 2.8350
Fibonacci 38.2% 2.4586
Last Price 1.9000
52-Week Low 1.2400

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar